This is a service of EIN News a digital news provider
Pharmaceutical Industry Today
Sign up for a free trial
Register Now
Member center Log In
Central America Cancer Drugs News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Central America Pharmaceuticals.
FORMATS: RSS | EMAIL

Latest Central America Cancer Drugs News

Sort by: relevance (24 hours) relevance date
  • Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5 Dec 2009 14:51 GMT
    ... NEW ORLEANS, Dec. 5 /PRNewswire-USNewswire/ -- Leukemia and myeloproliferative disorders are serious and often ... disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual ... derivative of Vitamin A, and an anthracycline-based chemotherapy; this results in a five-year overall survival ...

  • Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferativ 5 Dec 2009 14:52 GMT
    ... Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders NEW ORLEANS, Dec. 5 ... disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual ... derivative of Vitamin A, and an anthracycline-based chemotherapy; this results in a five-year overall survival ...

  • Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia a 5 Dec 2009 15:10 GMT
    ... Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders Advances in Genetic Understanding ... disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual ... derivative of Vitamin A, and an anthracycline-based chemotherapy; this results in a five-year overall survival ...

  • Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders (PRN) 5 Dec 2009 14:55 GMT
    ... improving the survival of patients with blood cancers and other bone marrow disorders like myelofibrosis," ... Improving the Treatment Outcome of Acute Promyelocytic Leukemia in Developing Countries Through International Cooperative Network. ... derivative of Vitamin A, and an anthracycline-based chemotherapy; this results in a five-year overall survival ...

  • New treatment options for leukemia and myeloproliferative disorders introduced 7 Dec 2009 06:17 GMT
    ... disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual ... evidence-based guidelines such as those of the EuropeanLeukemiaNET, is a combination of all-trans retinoic acid, ... derivative of Vitamin A, and an anthracycline-based chemotherapy; this results in a five-year overall survival ...

  • President Museveni tours Cuba schools 2 Dec 2009 21:47 GMT
    ... and Janet welcomed by Ugandan students at Cuba International School of Physical Education and Sports ... the Ugandan delegation that the institution produces vaccines and other diagnostics for the country’s livestock. ... that Cuban scientists had registered successes in cancer research and had produced various vaccines. Museveni recommended ...

  • Drugs: What a waste 30 Nov 2009 06:11 GMT
    ... At the Windham Solid Waste Management District (WSWMD), we ... expired, unused, spilt and contaminated pharmaceutical products, drugs and vaccines. Historically, the hospital incinerators and ... warfarin, nicotine, epinephrine, nitroglycerin, and even some chemotherapy agents actually meet the definition of hazardous ...

  • HPV Vaccine: Continuous Protection Beyond Six Years 4 Dec 2009 08:34 GMT
    ... that the 'Cervarix' human papilloma virus (HPV) vaccine from GlaxoSmithKline offers continued protection beyond six ... of Dr Cosette Wheeler, University of New Mexico, Health Sciences Center, Albuquerque, NM, USA, and ... GlaxoSmithKline Vaccine HPV-007 study group. Worldwide, cervical cancer is the second most common malignant disease in women. ...

  • UPDATE 2-FDA fast tracks Aeterna, Keryx cancer drug 2 Dec 2009 15:54 GMT
    ... * Cancer drug receives fast track approval * Perifosine in Phase ... ) in the United States, Canada and Mexico. Aeterna shares were up 7.6 percent at ...

  • CUBA: BIOTECH EXPORT SALES SHOWING GROWTH 2 Dec 2009 05:39 GMT
    ... Dec. 1, 2009 (IPS/GIN) - The promising anti-cancer antibody nimotuzumab, developed by Agust¡n Lage, head of ... 20 years ago, has recently produced a vaccine against hepatitis B, a synthetic vaccine against ... quality of life. In mid-2009, the Canada-based drug development company YM Biosciences obtained a licence for ...

  • Colonel beats cancer, soars high 3 Dec 2009 08:14 GMT
    ... a long way since being diagnosed with cancer in 2006. "I was diagnosed with cancer when I ... local hematologist/oncologist who managed my case, and TRICARE sent me to the University of Texas ... am extremely thankful for it." A new drug worked a miracle and caused the F-22 pilot's ...

  • Scientists report cervarix vaccine offers protection against cervical cancer 5 Dec 2009 06:29 GMT
    ... The Cervarix vaccine provides protection against two types of human ... HPV. Scientists at the University of New Mexico and GlaxoSmithKline have now combined results from ... every case. None of the women developed pre-cancerous changes as a result of HPV 16 or ...

  • Vaccine against cervical cancer 'protects for at least six years' 3 Dec 2009 08:17 GMT
    ... the offer. A study conducted in New Mexico comparing the number of vaccinated girls who became infected with strains 16 ... of the International Agency for Research on Cancer, in Lyons, France, wrote in an accompanying editorial. ...

  • AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2 Dec 2009 13:51 GMT
    ... today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ... Zentaris. "We further believe that this North American clinical development program will also be very ... multiple myeloma. Perifosine is a novel oral anticancer agent that modulates several key signal transduction pathways, ...

  • Ăterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2 Dec 2009 13:53 GMT
    ... Æterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation ... today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ... Zentaris. "We further believe that this North American clinical development program will also be very ...


1 - 15 / 241      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS CENTRAL AMERICA CANCER DRUGS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

For which of the following topics do you have the biggest problem finding news on the Internet? (Nov. 27, 2009)














 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.